Jason Murata
{ Bio Portrait }

Jason Murata is a partner in the intellectual property litigation group and chair of Axinn's Diversity, Equity & Inclusion Committee. Jason's practice involves all aspects of pre-trial, trial and appeals, with a particular focus on the pharmaceutical and biopharmaceutical, technology, consumer products, and food industries. He also brings extensive litigation experience to bear on complex issues relating to managing a company's IP risks and freedom to operate.

Professional Activities

  • American Intellectual Property Law Association, Committee on Nominations (2024)
  • American Intellectual Property Law Association, Committee on the Profession
  • American Bar Association, Section of Intellectual Property Law


  • Mayne Pharma Int’l Pty Ltd. v. Merck & Co., Inc., No. 15-cv-00438 (D. Del.) (patent infringement action relating to Merck’s Noxafil posaconazole products)

  • Globus Medical, Inc. v. DePuy Synthes Products, LLC, No. 13-cv-00854 (D. Del.) (defend patent infringement action relating to spinal fusion implants)
  • Otsuka Pharmaceutical Co., Ltd. v. Zydus Pharmaceuticals USA Inc., Nos. 14-cv-03158-JBS-KMW & 14-cv-07252-JBS-KMW (D.N.J.) (obtained denial of motion for temporary restraining order in patent infringement action relating to generic aripiprazole drug product (Abilify))

  • Pfizer, Inc. v. Tiger Pharmaceuticals, LLC, No. 14-cv-01501-AJT-TRJ (E.D. Va.); Pfizer, Inc. v. Tiger Pharmaceuticals, LLC, No. 14-cv-08958-GHW (S.D.N.Y.); Johnson Matthey Inc. v. Pfizer, Inc., 2:15-cv-00014-AWA-TEM (E.D. Va.) (obtained dismissal of patent infringement action relating to dofetilide drug product within four months of filing of the action)

  • Depomed, Inc. v. Actavis Elizabeth LLC, No. 3:12-cv-01358 (D.N.J.) and Appeal No. 14-1828 (Fed. Cir.) (bench trial in patent infringement action relating to generic once-daily gabapentin product)

  • The Procter & Gamble Co. v. Conopco, Inc., No. 13-CV-00732-TSB (S.D. Ohio) (represented Unilever in patent infringement action relating to antidandruff shampoo products)

  • Brandeis University v. Unilever United States, Inc., No. 12-cv-01510 (N.D. Ill.) (Posner, J.) (represented Unilever in patent infringement action brought by marketer of SmartBalance products relating to margarines and buttery spreads)

  • Hospira, Inc. v. Sun Pharmaceutical Industries, Inc., No. 2:10-cv-14514 (BAF/MJH) (E.D. Mich.) (defense of patent infringement action relating to generic dexemdetomidine drug product)

  • Tyco Healthcare Group LP, et al. v Mutual Pharmaceutical Co., Inc., et al., Civil Action No. 07-cv-1299 (D.N.J.) and Appeal No. 2010-1513 (Fed. Cir.) (obtained summary judgment of invalidity that asserted patent was obvious, which was affirmed by Federal Circuit)
  • In re Gabapentin Patent Litigation, MDL No. 1384, Master Civil Action No. 00-2931 (D.N.J.) (patent infringement dispute involving gabapentin)
  • Aventis Pharmaceuticals Inc., et al. v. Sun Pharma Global Inc., et al., Civil Action Nos.  09-cv-00325 & -05179; Civil Action No.: 2:09-cv-5179-JAG (D.N.J.) (patent infringement dispute involving fexofenadine and fexofenadine / pseudoephedrine products)
  • Roche Palo Alto LLC. v. Endo Pharmaceuticals Inc., Civil Action No. 10-cv-00261-GMS (D. Del.) (patent infringement dispute involving valganciclovir hydrochloride)
  • United States Gypsum Co. v. Lafarge North America, Inc., Lafarge S.A., et al., Civil Action No. 03-CV-6027 (N.D. Ill. 2003) (theft of confidential, proprietary and trade secret information and patent infringement involving gypsum drywall manufacturing)
  • Pall Corp. v. Entegris, Inc., Civil Action No. 07-CV-1869 (E.D.N.Y. 2007) (infringement dispute concerning filter media packing and capsule design)
  •  Pall Corp. v. Entegris, Inc., Civil Action No. 05-CV-5894 (E.D.N.Y. 2005) (patent infringement dispute involving filter assembly methods and pre-wet packaging)
  • Entegris, Inc. v. Pall Corp., Appeal Nos. 2004-1440, 2005-1265, -1266, 2006-1374 (Fed. Cir. 2006) (appeal from preliminary injunction and contempt order in patent infringement dispute concerning filter assembly)
  • AstraZeneca AB, et al. v. Mutual Pharmaceutical Co., Inc., Appeal No. 04-1100 (Fed. Cir. 2004) (appeal in pharmaceutical case relating to generic extended-release felodipine tablets)
  • Ciba Specialty Chemicals Corp. v. Zinkan Enterprises Inc., et al., Civil Action No. C2 03 174 (S.D. Ohio 2002) (patent infringement dispute involving treatment of wastewater from coal mining) 


  • Profiles in Diversity Journal Asian Leadership Award Winner (2023)
  • New Leaders in the Law – Connecticut Law Tribune (2014) 

Thought Leadership



  • JD – Washington University School of Law (2002)
  • MA, Biology – Washington University (2002)
  • BS, Biochemistry – McMaster University (1999)


  • California
  • Connecticut
  • Illinois
  • New York
  • U.S. Court of Appeals for the Federal Circuit
  • U.S. District Court Northern District of Illinois
  • U.S. District Court Northern District of California

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.